<unk>  is a selective beta1 receptor blocker used in treatment of several diseases of the
cardiovascular system, especially hypertension. It is marketed under the brand name Lopressor or Lopresor, respectively, by Novartis, and Toprol-XL (in the USA); Seleken or Selokeen (elsewhere); as Minax by Alphapharm (in Australia), Metrol by Arrow Pharmaceuticals (in Australia), as Betaloc by AstraZeneca, as Neobloc by Unipharm (in Israel) and as Corvitol by Berlin-Chemie AG.  A number of generic products is available, too. The active substance<unk>  is employed either as<unk>  succinate or<unk>  tartrate (whereas 100 mg<unk>  tartrate corresponds to 95 mg<unk>  succinate), as conventional release- or prolonged-release formulation.
Metoprolol detailed information
Esmolol detailed information
Rosiglitazone detailed information
Tocainide detailed information
Hypertension additional tests
Glimepiride detailed information
Cilostazol detailed information
Salmeterol detailed information